Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence
2019 ◽
Vol 36
(05)
◽
pp. 367-373
◽
Keyword(s):
AbstractRenal cell carcinoma (RCC) is most commonly diagnosed at an early (T1a) stage and is typically amenable to several effective treatments. The current gold standard therapy is partial nephrectomy, given its decreased morbidity and similar oncologic outcomes when compared with radical nephrectomy. Thermal ablation is an evolving definitive therapy for T1a RCC which is even less invasive than partial nephrectomy. This article reviews the evidence for thermal ablation in the treatment of T1a RCC and compares outcomes of existing ablation modalities with surgical management.
2020 ◽
Vol 31
(3)
◽
pp. S119-S120
Keyword(s):
2015 ◽
Vol 193
(2)
◽
pp. 430-435
◽
Keyword(s):
2020 ◽
Vol 31
(4)
◽
pp. 564-571
◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 29
(4)
◽
pp. S108
Keyword(s):
Keyword(s):
2021 ◽
Vol 32
(1)
◽
pp. 33-38
Keyword(s):
Keyword(s):